Laurus Labs Ltd NSE/BSE Share

Q: How to Buy Laurus Labs Ltd Stock?

<div> Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders. <div> 1. Login to the Kuvera app or website and go to Invest section. </div> <div> 2. Select stocks and search for Laurus Labs Ltd or scroll over to Laurus Labs Ltd </div> <div> 3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction. </div> </div>

Q: What is the Share Price of Laurus Labs Ltd?

<div>The share price of Laurus Labs Ltd stocks is ₹447.30 as on 05/05/2024</div>

Q: What is the Market Cap of Laurus Labs Ltd?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Laurus Labs Ltd stock is ₹24,107.9 Cr on 05/05/2024.</div>

Q: In which sector / industry does Laurus Labs Ltd operate?

<div>Laurus Labs Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.</div>

Q: What was the revenue of Laurus Labs Ltd?

<div>The revenue of Laurus Labs Ltd as of 2023 was ₹5,040.8 Cr</div>

Q: What is the PE ratio of Laurus Labs Ltd?

<div>The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. P/E ratio of Laurus Labs Ltd is 128.90 as on 05/05/2024.</div>

Q: What is the 52 week high price of Laurus Labs Ltd?

<div> The 52 week high of Laurus Labs Ltd stock is ₹470.90. </div>

Q: What is the 52 week low price of Laurus Labs Ltd?

<div> The 52 week low of Laurus Labs Ltd stock is ₹299.30. </div>

Q: Can fractional shares of Laurus Labs Ltd be purchased?

<div>No, you cannot buy fractional shares of Laurus Labs Ltd, or any listed Indian company as of now.</div>

Healthcare Drug Manufacturers - Specialty & Generic

₹447.30

-2.4

(3 May)

-0.5%

Loading chart

Price

₹447.30

Today’s high

₹453.70

Today’s low

₹442.15

52W high

₹470.90

52W low

₹299.30

43.8%

128.90

5.86

EPS (TTM)

2.98

Dividend yield

0.2%

41.5%

Market cap

₹24,107.9 Cr

Volume

30,304

Average volume

78,585

Insights

LAURUSLABS has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

LAURUSLABS price is above its 200 day moving average

LAURUSLABS PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.

In beta. Send feedback here.

Compare with other stock

₹1,663.00

₹1,152.50

₹1,508.40

₹447.30

₹6,332.85

₹3,937.05

+0.9%

-0.1%

-0.7%

-0.5%

+0.7%

-0.7%

+134.7%

+86.4%

+55.1%

+43.8%

+27.8%

+21.0%

42.45

24.40

40.66

128.90

20.21

75.55

5.72

2.40

6.05

5.86

3.94

8.24

39.18

47.24

37.10

3.47

313.29

52.11

Large

Financials

Income statement

Balance sheet

Cash flow

Quarterly

Annual

As of 2023

Revenue

₹5,040.8 Cr

Net income

₹160.6 Cr

See stock holdings

Top institutional holders

Capital Research and Management Company

11.04%

Mirae Asset Global Inv (India) Pvt. Ltd

3.06%

Vanguard Group Inc

2.17%

Capital Guardian Trust Company

2.02%

Kotak Mahindra Asset Management (Singapore) Pte. Ltd

1.33%

Top mutual fund holders

American Funds New World Fund

6.50%

American Funds SMALLCAP World Fund

4.10%

Capital Group Emerg Mkts Debt (USD) Tr

2.02%

Kotak India Midcap Diversified Fund

1.33%

Mirae Asset ELSS Tax Saver

1.30%

About Laurus Labs

Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.

Company address

Road No. 7, Banjara Hills, 2nd Floor, Serene Chambers, Hyderabad, TG, 500034

Company URL

https://www.lauruslabs.com

Key executives

Name

Title

Age

Dr. Satyanarayana Chava

CEO/Director

61 yrs

Mr. V. V. Ravi Kumar

CFO/Director

Mr. Venkata Ravi Kumar Vantaram

CFO/Director

57 yrs

FAQs

How to Buy Laurus Labs Ltd Stock?

What is the Share Price of Laurus Labs Ltd?

What is the Market Cap of Laurus Labs Ltd?

In which sector / industry does Laurus Labs Ltd operate?

What was the revenue of Laurus Labs Ltd?

What is the PE ratio of Laurus Labs Ltd?

What is the 52 week high price of Laurus Labs Ltd?

What is the 52 week low price of Laurus Labs Ltd?

Can fractional shares of Laurus Labs Ltd be purchased?